US Stock MarketDetailed Quotes

BCYC Bicycle Therapeutics

Watchlist
  • 12.550
  • +0.060+0.48%
Close Feb 14 16:00 ET
  • 12.550
  • 0.0000.00%
Post 20:01 ET
866.53MMarket Cap-3.83P/E (TTM)

About Bicycle Therapeutics Company

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Company Profile

SymbolBCYC
Company NameBicycle Therapeutics
Listing DateMay 23, 2019
Issue Price14.00
Founded2009
CEODr. Kevin Lee, M.B.A.
MarketNASDAQ
Employees284
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressGranta Park Great Abington,Portway Building,Blocks A & B
CityCambridge
ProvinceCambridgeshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCB21 6GS
Phone44-1223-261503
Websitehttp://bicycletherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Kevin Lee, M.B.A.
  • Director and Chief Executive Officer
  • 5.54M
  • Dr. Michael Skynner, PhD
  • Chief Technology Officer
  • --
  • Dr. Santiago Arroyo
  • Chief Development Officer
  • 2.68M
  • Dr. Michael Charles Ferguson Hannay, D.Sc.
  • Chief Product and Supply Chain Officer
  • --
  • Alethia Young
  • Chief Financial Officer
  • 2.88M
  • Nigel Crockett
  • Chief Business Officer
  • --
  • Alistair Milnes
  • Chief Operating Officer
  • --
  • Dr. Nicholas Keen, PhD
  • Chief Scientific Officer
  • --
  • Travis Thompson
  • Chief Accounting Officer
  • --
  • Pierre Legault, C.P.A.,M.B.A.
  • Chairman of the Board
  • 1.06M
  • Janice Bourque, M.B.A.
  • Independent Director
  • 495.41K
  • Dr. Felix J. Baker,PhD
  • Independent Director
  • --
  • Richard N. Kender, M.B.A.
  • Independent Director
  • 526.91K
  • Stephen Sands
  • Independent Director
  • --
  • Sir Greg Winter, F.R.S.
  • Independent Director
  • 477.04K
  • Dr. Jose-Carlos Gutierrez-Ramos, PhD
  • Independent Director
  • 482.29K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!